AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Board/Management Information Nov 7, 2022

4780_rns_2022-11-07_adf83f15-b9f2-4949-a4bb-309302336ad6.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5408F

Primary Health Properties PLC

07 November 2022

Primary Health Properties PLC

("PHP" or "Company")

Appointment of Joint Corporate Broker

Primary Health Properties PLC, one of the UK's largest providers of modern primary healthcare facilities, announces that it has appointed JP Morgan Securities plc (trading as JP Morgan Cazenove) as joint corporate broker to the Company with immediate effect.  JP Morgan Cazenove will work alongside Primary Health Properties' existing brokers, Numis Securities Limited and Peel Hunt LLP.

Harry Hyman, Chief Executive Officer, commented:

"PHP is pleased to have JP Morgan Cazenove on board as a partner. They have a breadth of advisory and broking experience as well as a successful track record in working with companies like PHP.  We look forward to the future with confidence."

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

Further details:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 7973 344768

Richard Howell

Chief Financial Officer

Tel: +44 (0) 7766 072272

David Rydell / Steph Whitmore / Hannah Ratcliff

(Buchanan Communications)

Tel: +44 (0) 20 7466 5066

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPGZMGMMNVGZZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.